Quick Answer
IO Biotech, Inc. reported Net Income of -$95.49 million for fiscal year 2024.
IO Biotech, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$95.49M | -10.9% |
| 2023 | -$86.08M | -20.5% |
| 2022 | -$71.46M | -5.3% |
| 2021 | -$67.88M | -463.7% |
| 2020 | -$12.04M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$8.38M | +65.1% | +68.0% |
| June 30, 2025 | -$26.22M | -26.7% | -16.9% |
| March 31, 2025 | -$22.42M | -15.2% | +6.6% |
| September 30, 2024 | -$24.02M | -10.8% | -16.1% |
| June 30, 2024 | -$20.69M | +2.3% | -6.3% |
| March 31, 2024 | -$19.46M | -14.2% | +10.2% |
| September 30, 2023 | -$21.68M | -38.2% | -2.4% |
| June 30, 2023 | -$21.18M | -14.5% | -24.3% |
- IO Biotech, Inc. showed a decrease of -10.9% in Net Income compared to the prior fiscal year.
- Over the 2020–2024 period, IO Biotech, Inc.’s net income has declined by 693.0% (from -$12.04 million to -$95.49 million).
- The most recent figure is from IO Biotech, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: